> top > docs > PubMed:12949798 > annotations

PubMed:12949798 JSONTXT

Annnotations TAB JSON ListView MergeView

DisGeNET5_variant_disease

Id Subject Object Predicate Lexical cue
12949798-0#0#9#geners4792311 217-226 geners4792311 denotes Ser217Leu
12949798-0#62#78#diseaseC0376358 1339-1599 diseaseC0376358 denotes patients with PCa or BPH and all control subjects had the Ala/Ala genotype. At codon 627, the incidence of the Leu variant was slightly, but not significantly, higher in patients with BPH than in controls (7.0% vs. 2.8%, odds ratio = 2.59, 95% confidence inter
12949798-15#46#55#geners4792311 1857-1866 geners4792311 denotes Ser217Leu
12949798-15#78#81#diseaseC2931456 1889-1892 diseaseC2931456 denotes PCa
12949798-15#184#187#diseaseC2931456 1995-1998 diseaseC2931456 denotes PCa
12949798-6#88#97#geners78105154 763-772 geners78105154 denotes Ser627Leu
12949798-6#46#49#diseaseC2931456 721-724 diseaseC2931456 denotes PCa
12949798-6#61#64#diseaseC1704272 736-739 diseaseC1704272 denotes BPH
0#9#geners479231162#78#diseaseC0376358 12949798-0#0#9#geners4792311 12949798-0#62#78#diseaseC0376358 associated_with Ser217Leu,"patients with PCa or BPH and all control subjects had the Ala/Ala genotype. At codon 627, the incidence of the Leu variant was slightly, but not significantly, higher in patients with BPH than in controls (7.0% vs. 2.8%, odds ratio = 2.59, 95% confidence inter"
46#55#geners479231178#81#diseaseC2931456 12949798-15#46#55#geners4792311 12949798-15#78#81#diseaseC2931456 associated_with Ser217Leu,PCa
46#55#geners4792311184#187#diseaseC2931456 12949798-15#46#55#geners4792311 12949798-15#184#187#diseaseC2931456 associated_with Ser217Leu,PCa
88#97#geners7810515446#49#diseaseC2931456 12949798-6#88#97#geners78105154 12949798-6#46#49#diseaseC2931456 associated_with Ser627Leu,PCa
88#97#geners7810515461#64#diseaseC1704272 12949798-6#88#97#geners78105154 12949798-6#61#64#diseaseC1704272 associated_with Ser627Leu,BPH

DisGeNET5_gene_disease

Id Subject Object Predicate Lexical cue
12949798-0#30#34#gene8535 738-826 gene8535 denotes H (n=143) using 1 novel (Ser627Leu) and 2 previously described polymorphisms of the HPC2
12949798-0#30#34#gene60528 738-826 gene60528 denotes H (n=143) using 1 novel (Ser627Leu) and 2 previously described polymorphisms of the HPC2
12949798-0#30#34#gene7834 738-826 gene7834 denotes H (n=143) using 1 novel (Ser627Leu) and 2 previously described polymorphisms of the HPC2
12949798-0#35#40#gene60528 827-832 gene60528 denotes ELAC2
12949798-0#62#78#diseaseC0376358 1339-1599 diseaseC0376358 denotes patients with PCa or BPH and all control subjects had the Ala/Ala genotype. At codon 627, the incidence of the Leu variant was slightly, but not significantly, higher in patients with BPH than in controls (7.0% vs. 2.8%, odds ratio = 2.59, 95% confidence inter
12949798-0#62#78#diseaseC0376358 1339-1599 diseaseC0376358 denotes patients with PCa or BPH and all control subjects had the Ala/Ala genotype. At codon 627, the incidence of the Leu variant was slightly, but not significantly, higher in patients with BPH than in controls (7.0% vs. 2.8%, odds ratio = 2.59, 95% confidence inter
12949798-13#48#52#gene8535 1695-1699 gene8535 denotes HPC2
12949798-13#48#52#gene60528 1695-1699 gene60528 denotes HPC2
12949798-13#48#52#gene7834 1695-1699 gene7834 denotes HPC2
12949798-13#53#58#gene60528 1700-1705 gene60528 denotes ELAC2
12949798-13#75#78#diseaseC2931456 1722-1725 diseaseC2931456 denotes PCa
12949798-13#75#78#diseaseC2931456 1722-1725 diseaseC2931456 denotes PCa
12949798-6#147#151#gene8535 822-826 gene8535 denotes HPC2
12949798-6#147#151#gene60528 822-826 gene60528 denotes HPC2
12949798-6#147#151#gene7834 822-826 gene7834 denotes HPC2
12949798-6#152#157#gene60528 827-832 gene60528 denotes ELAC2
12949798-6#61#64#diseaseC1704272 736-739 diseaseC1704272 denotes BPH
12949798-6#61#64#diseaseC1704272 736-739 diseaseC1704272 denotes BPH
30#34#gene853562#78#diseaseC0376358 12949798-0#30#34#gene8535 12949798-0#62#78#diseaseC0376358 associated_with H (n=143) using 1 novel (Ser627Leu) and 2 previously described polymorphisms of the HPC2,"patients with PCa or BPH and all control subjects had the Ala/Ala genotype. At codon 627, the incidence of the Leu variant was slightly, but not significantly, higher in patients with BPH than in controls (7.0% vs. 2.8%, odds ratio = 2.59, 95% confidence inter"
30#34#gene853562#78#diseaseC0376358 12949798-0#30#34#gene8535 12949798-0#62#78#diseaseC0376358 associated_with H (n=143) using 1 novel (Ser627Leu) and 2 previously described polymorphisms of the HPC2,"patients with PCa or BPH and all control subjects had the Ala/Ala genotype. At codon 627, the incidence of the Leu variant was slightly, but not significantly, higher in patients with BPH than in controls (7.0% vs. 2.8%, odds ratio = 2.59, 95% confidence inter"
30#34#gene6052862#78#diseaseC0376358 12949798-0#30#34#gene60528 12949798-0#62#78#diseaseC0376358 associated_with H (n=143) using 1 novel (Ser627Leu) and 2 previously described polymorphisms of the HPC2,"patients with PCa or BPH and all control subjects had the Ala/Ala genotype. At codon 627, the incidence of the Leu variant was slightly, but not significantly, higher in patients with BPH than in controls (7.0% vs. 2.8%, odds ratio = 2.59, 95% confidence inter"
30#34#gene6052862#78#diseaseC0376358 12949798-0#30#34#gene60528 12949798-0#62#78#diseaseC0376358 associated_with H (n=143) using 1 novel (Ser627Leu) and 2 previously described polymorphisms of the HPC2,"patients with PCa or BPH and all control subjects had the Ala/Ala genotype. At codon 627, the incidence of the Leu variant was slightly, but not significantly, higher in patients with BPH than in controls (7.0% vs. 2.8%, odds ratio = 2.59, 95% confidence inter"
30#34#gene783462#78#diseaseC0376358 12949798-0#30#34#gene7834 12949798-0#62#78#diseaseC0376358 associated_with H (n=143) using 1 novel (Ser627Leu) and 2 previously described polymorphisms of the HPC2,"patients with PCa or BPH and all control subjects had the Ala/Ala genotype. At codon 627, the incidence of the Leu variant was slightly, but not significantly, higher in patients with BPH than in controls (7.0% vs. 2.8%, odds ratio = 2.59, 95% confidence inter"
30#34#gene783462#78#diseaseC0376358 12949798-0#30#34#gene7834 12949798-0#62#78#diseaseC0376358 associated_with H (n=143) using 1 novel (Ser627Leu) and 2 previously described polymorphisms of the HPC2,"patients with PCa or BPH and all control subjects had the Ala/Ala genotype. At codon 627, the incidence of the Leu variant was slightly, but not significantly, higher in patients with BPH than in controls (7.0% vs. 2.8%, odds ratio = 2.59, 95% confidence inter"
35#40#gene6052862#78#diseaseC0376358 12949798-0#35#40#gene60528 12949798-0#62#78#diseaseC0376358 associated_with ELAC2,"patients with PCa or BPH and all control subjects had the Ala/Ala genotype. At codon 627, the incidence of the Leu variant was slightly, but not significantly, higher in patients with BPH than in controls (7.0% vs. 2.8%, odds ratio = 2.59, 95% confidence inter"
35#40#gene6052862#78#diseaseC0376358 12949798-0#35#40#gene60528 12949798-0#62#78#diseaseC0376358 associated_with ELAC2,"patients with PCa or BPH and all control subjects had the Ala/Ala genotype. At codon 627, the incidence of the Leu variant was slightly, but not significantly, higher in patients with BPH than in controls (7.0% vs. 2.8%, odds ratio = 2.59, 95% confidence inter"
48#52#gene853575#78#diseaseC2931456 12949798-13#48#52#gene8535 12949798-13#75#78#diseaseC2931456 associated_with HPC2,PCa
48#52#gene853575#78#diseaseC2931456 12949798-13#48#52#gene8535 12949798-13#75#78#diseaseC2931456 associated_with HPC2,PCa
48#52#gene6052875#78#diseaseC2931456 12949798-13#48#52#gene60528 12949798-13#75#78#diseaseC2931456 associated_with HPC2,PCa
48#52#gene6052875#78#diseaseC2931456 12949798-13#48#52#gene60528 12949798-13#75#78#diseaseC2931456 associated_with HPC2,PCa
48#52#gene783475#78#diseaseC2931456 12949798-13#48#52#gene7834 12949798-13#75#78#diseaseC2931456 associated_with HPC2,PCa
48#52#gene783475#78#diseaseC2931456 12949798-13#48#52#gene7834 12949798-13#75#78#diseaseC2931456 associated_with HPC2,PCa
53#58#gene6052875#78#diseaseC2931456 12949798-13#53#58#gene60528 12949798-13#75#78#diseaseC2931456 associated_with ELAC2,PCa
53#58#gene6052875#78#diseaseC2931456 12949798-13#53#58#gene60528 12949798-13#75#78#diseaseC2931456 associated_with ELAC2,PCa
147#151#gene853561#64#diseaseC1704272 12949798-6#147#151#gene8535 12949798-6#61#64#diseaseC1704272 associated_with HPC2,BPH
147#151#gene853561#64#diseaseC1704272 12949798-6#147#151#gene8535 12949798-6#61#64#diseaseC1704272 associated_with HPC2,BPH
147#151#gene6052861#64#diseaseC1704272 12949798-6#147#151#gene60528 12949798-6#61#64#diseaseC1704272 associated_with HPC2,BPH
147#151#gene6052861#64#diseaseC1704272 12949798-6#147#151#gene60528 12949798-6#61#64#diseaseC1704272 associated_with HPC2,BPH
147#151#gene783461#64#diseaseC1704272 12949798-6#147#151#gene7834 12949798-6#61#64#diseaseC1704272 associated_with HPC2,BPH
147#151#gene783461#64#diseaseC1704272 12949798-6#147#151#gene7834 12949798-6#61#64#diseaseC1704272 associated_with HPC2,BPH
152#157#gene6052861#64#diseaseC1704272 12949798-6#152#157#gene60528 12949798-6#61#64#diseaseC1704272 associated_with ELAC2,BPH
152#157#gene6052861#64#diseaseC1704272 12949798-6#152#157#gene60528 12949798-6#61#64#diseaseC1704272 associated_with ELAC2,BPH

DisGeNET

Id Subject Object Predicate Lexical cue
T0 822-826 gene:60528 denotes HPC2
T1 736-739 disease:C1704272 denotes BPH
T2 827-832 gene:60528 denotes ELAC2
T3 736-739 disease:C1704272 denotes BPH
R1 T0 T1 associated_with HPC2,BPH
R2 T2 T3 associated_with ELAC2,BPH